Feb 20 |
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
|
Feb 14 |
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness
|
Feb 13 |
Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
|
Feb 12 |
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
|
Feb 9 |
Precision Biosciences to execute reverse stock split
|
Feb 9 |
Precision BioSciences to Effect a Reverse Stock Split
|
Jan 9 |
Precision BioSciences stock rises on $17.5M license deal with TG Therapeutic
|
Jan 9 |
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
|
Jan 9 |
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
|
Dec 13 |
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
|